Optomed PlcStock Exchange Release8 August 2025 at 15.30, Helsinki
Change in Optomed's holding of treasury shares
Optomed has conveyed 12,687 treasury shares to the members of the Board of
Directors as a part of the Board members' annual remuneration in accordance with
the decision of the Annual General Meeting 2025. The amount of shares is based
on the monthly remuneration decided by the Annual General Meeting and Optomed's
value weighted average share price between 31 July and 6 August 2025.
The total amount of treasury shares is now 22,042.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld cameras with software and
artificial intelligence with the aim to transform the diagnostic process of
blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its
business Optomed focuses on eye-screening devices and software solutions related
R&D in Finland and sales through different channels in over 60 countries.